Moderna Inc
Change company Symbol lookup
Select an option...
MRNA Moderna Inc
NRG NRG Energy Inc
CYD China Yuchai International Ltd
FST FAST Acquisition Corp
AAPL Apple Inc
AMZN Amazon.com Inc
GDS GDS Holdings Ltd
DX Dynex Capital Inc
IMUX Immunic Inc
VLO Valero Energy Corp
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company has created modalities, including Prophylactic vaccines, Systemic secreted and cell surface therapeutics, Cancer vaccines, Intratumoral immuno-oncology, Localized regenerative therapeutics, and Systemic intracellular therapeutics. Its diverse development pipeline which consists of 27 development candidates across its 24 programs.

Postmarket

Last Trade
Delayed
$339.40
-0.17 (-0.05%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$339.57
Day's Change
6.56 (1.97%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
341.52
Day's Low
333.40
Volume
(Light)
Volume:
5,496,244

10-day average volume:
10,940,160
5,496,244

Display:

Providers:

UpdateCancel
6 providers
Yesterday's News, October 20, 2021
Moderna Announces FDA Authorization of a Booster Dose of Moderna's COVID-19 Vaccine in the U.S.

--FDA also authorized the use of Moderna's booster dose following primary vaccination with other authorized or approved COVID-19 vaccines Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...(BusinessWire)

Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine

FinancialNewsMedia.com News Commentary - Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing SARS-CoV-2, as well as other coronaviruses such as those causing SARS and MERS, produced...(PR Newswire)

October 15, 2021
Thinking about trading options or stock in Bank of America, Moderna, Alcoa, Apple, or UnitedHealth Group?

InvestorsObserver issues critical PriceWatch Alerts for BAC, MRNA, AA, AAPL, and UNH. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

October 14, 2021
Moderna Announces FDA Advisory Committee Unanimously Votes in Support of Emergency Use for a Booster Dose of Moderna's COVID-19 Vaccine in the U.S.

--Company estimates that booster at the 50 ug dose level could result in up to 1 billion additional doses Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today confirmed that the U.S...(BusinessWire)

Moderna to Report Third Quarter Financial Results on Thursday, November 4, 2021

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 4, 2021 to report its third...(BusinessWire)

October 13, 2021
Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change

Invaio Sciences, Inc., a Flagship Pioneering company unlocking the potential of natural systems to accelerate the transition to sustainable agriculture to urgently address climate change, has entered into a $50 million loan and security agreement...(PR Newswire)

October 12, 2021
Moderna Announces COVAX Exercises Option to Purchase 176.5 Million Additional Doses of Moderna's COVID-19 Vaccine for Low Income Countries in First Half of 2022

--COVAX has options to purchase an additional 233 million doses in second half of 2022 --Doses provided at lowest tiered price, in keeping with Moderna's global access principles --Moderna has requested authorization of a 50 ug booster dose from...(BusinessWire)

October 07, 2021
Thinking about trading options or stock in Apple, Moderna, AT&T, Pfizer, or Palantir Technologies?

InvestorsObserver issues critical PriceWatch Alerts for AAPL, MRNA, T, PFE, and PLTR. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Moderna to Build State-of-the-Art mRNA Facility in Africa to Manufacture up to 500 Million Doses Per Year

--Moderna will invest in building mRNA capabilities in Africa Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it will build a state-of-the-art mRNA facility in Africa...(BusinessWire)

October 06, 2021
Moderna Announces the Launch of Global Fellowship Program for Young Researchers Exploring mRNA Medicines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the launch of the Moderna Fellowship Program. The goal of the program is to support the next generation of scientists...(BusinessWire)

October 05, 2021
Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the European Medicines Agency (EMA) has authorized a third dose of the Moderna COVID-19 vaccine (Spikevax) given at...(BusinessWire)

October 04, 2021
Thinking about trading options or stock in General Motors, Moderna, Occidental Petroleum, Facebook, or Exxon Mobil?

InvestorsObserver issues critical PriceWatch Alerts for GM, MRNA, OXY, FB, and XOM. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

October 01, 2021
Thinking about trading options or stock in Advanced Micro Devices, Inmode, Caesars Entertainment, Nio, or Moderna?

InvestorsObserver issues critical PriceWatch Alerts for AMD, INMD, CZR, NIO, and MRNA. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

September 30, 2021
Moderna to Invest in New Science Center in Cambridge, MA

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it is investing in a new science center, known as the Moderna Science Center, at 325 Binney Street in Cambridge...(BusinessWire)

September 29, 2021
Thinking about trading options or stock in Dollar Tree, Asana, AstraZeneca, Moderna, or Winnebago?

InvestorsObserver issues critical PriceWatch Alerts for DLTR, ASAN, AZN, MRNA, and WGO. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

September 28, 2021
Why Some Experts Say for an Effective COVID Vaccine, Look Beyond Antibodies to T-Cells

FinancialNewsMedia.com News Commentary More than 100 companies have rushed into vaccine development against COVID-19 as the U.S. government pushes for a vaccine rollout at "warp speed" -- possibly by the end of the year -- but the bar set for an...(PR Newswire)

Moderna to Present at Chardan's Virtual 5th Annual Genetic Medicines Conference

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Stephen Hoge, M.D., President, will participate in a fireside chat at Chardan's Virtual 5th Annual Genetic...(BusinessWire)

September 24, 2021
Moderna Announces Supply Agreement with Peru for 20 Million Doses of Its COVID-19 Vaccine

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the government of Peru for 20 million doses of Moderna's COVID-19 vaccine to begin delivery in...(BusinessWire)

Thinking about trading options or stock in AstraZeneca, Microsoft, Walt Disney, Alibaba, or Moderna?

InvestorsObserver issues critical PriceWatch Alerts for AZN, MSFT, DIS, BABA, and MRNA. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

September 16, 2021
Moderna Announces Health Canada Approves its COVID-19 Vaccine

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced Health Canada has approved the New Drug Submission (NDS-CV) for SPIKEVAX(TM) (elasomeran mRNA vaccine), which has been...(BusinessWire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.